QSAR Model for Drug Human Oral Bioavailability

Fumitaka Yoshida; John G. Topliss

doi:10.1021/jm0000564

journal article Jun 01, 2000

QSAR Model for Drug Human Oral Bioavailability

Fumitaka Yoshida John G. Topliss

Journal of Medicinal Chemistry Vol. 43 No. 13 pp. 2575-2585 · American Chemical Society (ACS)

View at Publisher Save 10.1021/jm0000564

Topics

No keywords indexed for this article. Browse by subject →

References

36

[1]

(1999)

[2]

Austel, V.; Kutter, E. InQuantitative Structure−Activity Relationships of Drugs; Topliss J. G., Ed.; Academic Press: New York, 1983; pp 437−496. 10.1016/b978-0-12-695150-9.50015-5

[3]

Lien E. (1975)

[4]

Hansch C. (1995)

[5]

Hirono S Biol. Pharm. Bull. (1994) 10.1248/bpb.17.306

[6]

Kubinyi, H.QSAR: Hansch Analysis and Related Approaches:Methods andPrinciples in Medicinal Chemistry; Mannhold, R., Krogsgaard-Larson, P., Timmerman, H., Eds.; VCH: Weinheim, 1993; Vol 1, pp 100−101. 10.1002/9783527616824

[7]

(a)Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed.; Hardman, J. G., Limbird, L. E., Molinoff, P. B., Ruddon, R. W., Gilman, A. G., Eds.; McGraw-Hill: New York, 1996: pp 1712−1792.

[8]

(b)Handbook of Clinical Pharmacology; Bochner, F., Carruthers, G., Kampman, J., Steiner, J., Azarnoff, D. L., Eds.; Little, Brown and Company: Boston/Toronto 1983.

[9]

(c)Clin. Pharmacokinet.1990−1994, 18−25. 10.1108/eb054311

[10]

Handbook (1992)

[11]

(1999)

[12]

Hansch C. (1995)

[13]

[14]

Moriguchi I. Chem. Pharm. Bull. (1992) 10.1248/cpb.40.127

[15]

Scherrer R. A. J. Med. Chem. (1977) 10.1021/jm00211a010

[16]

(a)Wilson and Grisvold's Textbook of Organic Medicinal and PharmaceuticalChemistry, 9th ed.; Delgado, J. N., Remers, W. A., Eds.; J. B. Lipincott: Philadephia, 1991; pp 877−881.

[17]

(b)AHFS 94 Drug Information; American Society of Hospital Pharmacists, Inc. 1994.

[18]

(c)Principles of MedicinalChemistry, 4th ed.; Foye, W. O., Lemke, T. L., Williams, D. A., Eds.; Williams and Wilkins: Baltimore, 1995; pp 948−960.

[19]

(1996)

[20]

Physicians Desk Reference (1998)

[21]

Dressman J. B. J. Pharm. Sci. (1985) 10.1002/jps.2600740523

[22]

Takahashi Y. Bunseki Kagaku (1984) 10.2116/bunsekikagaku.33.11_e487

[23]

Sasaki S. Hazard Asses. Chem. (1986)

[24]

Takahashi Y. Quant. Struct.-Act. Relat. (1987) 10.1002/qsar.19870060105

[25]

Lien E. J Ann. Rev. Pharmacol. Toxicol. (1981)

[26]

Lipinsky C. A. Adv. Drug Deliv. Rev. (1997)

[27]

Zimm S. Clin. Pharmacol. Ther. (1983) 10.1038/clpt.1983.254

[28]

Nogami H. Pharm. Bull. (1968)

[29]

Tai A. W. Acta Pharm. Jugoslav. (1980)

[30]

Burton P. S. Adv. Drug Del. Rev. (1991) 10.1016/0169-409x(91)90014-4

[31]

von Geldern T. W. J. Med. Chem. (1996)

[32]

Walle T. J. Pharmacol. Exptl. Ther. (1972)

[33]

Debnath A. K. Environ. Mol. Mutagen. (1992)

[34]

Hansch C Drug Metab. Rev. (1972) 10.2174/187231207779814337

[35]

Hansch C. J. Med. Chem. (1965) 10.1021/jm00330a036

[36]

Beckett A. H. J. Pharm. Pharmacol. (1972)

Cited By

259

A Novel Chemometric Method for the Prediction of Human Oral Bioavailability

Xue Xu, Wuxia Zhang · 2012

International Journal of Molecular...

Integration of virtual and high-throughput screening

Jürgen Bajorath · 2002

Nature Reviews Drug Discovery

Metrics

259

Citations

36

References

Details

Published: Jun 01, 2000
Vol/Issue: 43(13)
Pages: 2575-2585

Authors

F

Fumitaka Yoshida

Division of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109-1065

J

John G. Topliss

Division of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109-1065

Cite This Article

Fumitaka Yoshida, John G. Topliss (2000). QSAR Model for Drug Human Oral Bioavailability. Journal of Medicinal Chemistry, 43(13), 2575-2585. https://doi.org/10.1021/jm0000564

QSAR Model for Drug Human Oral Bioavailability

You May Also Like